SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-010648
Filing Date
2023-03-29
Accepted
2023-03-29 16:58:31
Documents
22

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-20230329.htm   iXBRL DEF 14A 2110637
2 GRAPHIC img215256201_0.jpg GRAPHIC 17621
3 GRAPHIC img215256201_1.jpg GRAPHIC 4263
4 GRAPHIC img215256201_2.jpg GRAPHIC 17621
5 GRAPHIC img215256201_3.jpg GRAPHIC 51719
6 GRAPHIC img215256201_4.jpg GRAPHIC 34701
7 GRAPHIC img215256201_5.jpg GRAPHIC 4263
8 GRAPHIC img215256201_6.jpg GRAPHIC 650877
9 GRAPHIC img215256201_7.jpg GRAPHIC 475404
  Complete submission text file 0000950170-23-010648.txt   6217678

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230329.xsd EX-101.SCH 5061
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evok-20230329_def.xml EX-101.DEF 5239
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230329_lab.xml EX-101.LAB 10707
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230329_pre.xml EX-101.PRE 6745
16 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230329_htm.xml XML 243418
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 23775960
SIC: 2834 Pharmaceutical Preparations